AU2003255866A1 - Gp41 epitope and uses thereof for the treatment of hiv infections - Google Patents

Gp41 epitope and uses thereof for the treatment of hiv infections

Info

Publication number
AU2003255866A1
AU2003255866A1 AU2003255866A AU2003255866A AU2003255866A1 AU 2003255866 A1 AU2003255866 A1 AU 2003255866A1 AU 2003255866 A AU2003255866 A AU 2003255866A AU 2003255866 A AU2003255866 A AU 2003255866A AU 2003255866 A1 AU2003255866 A1 AU 2003255866A1
Authority
AU
Australia
Prior art keywords
epitope
treatment
hiv infections
hiv
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003255866A
Other versions
AU2003255866A8 (en
Inventor
Mario Clerici
Lucia Lopalco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Superiore di Sanita ISS
Universita degli Studi di Milano
Fondazione Centro San Raffaele del Monte Tabor
Original Assignee
SAN RAFFAELE CENTRO FOND
Fondazione Centro San Raffaele del Monte Tabor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAN RAFFAELE CENTRO FOND, Fondazione Centro San Raffaele del Monte Tabor filed Critical SAN RAFFAELE CENTRO FOND
Publication of AU2003255866A1 publication Critical patent/AU2003255866A1/en
Publication of AU2003255866A8 publication Critical patent/AU2003255866A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003255866A 2002-08-06 2003-08-05 Gp41 epitope and uses thereof for the treatment of hiv infections Abandoned AU2003255866A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2002A001781 2002-08-06
IT001781A ITMI20021781A1 (en) 2002-08-06 2002-08-06 GP41 EPITOPE AND ITS USES IN THE TREATMENT OF HIV INFECTIONS.
PCT/IB2003/003149 WO2004014945A1 (en) 2002-08-06 2003-08-05 Gp41 epitope and uses thereof for the treatment of hiv infections

Publications (2)

Publication Number Publication Date
AU2003255866A1 true AU2003255866A1 (en) 2004-02-25
AU2003255866A8 AU2003255866A8 (en) 2004-02-25

Family

ID=31503941

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255866A Abandoned AU2003255866A1 (en) 2002-08-06 2003-08-05 Gp41 epitope and uses thereof for the treatment of hiv infections

Country Status (3)

Country Link
AU (1) AU2003255866A1 (en)
IT (1) ITMI20021781A1 (en)
WO (1) WO2004014945A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2807181A1 (en) * 2012-01-26 2014-12-03 Institut National de la Santé et de la Recherche Médicale (INSERM) Vaccine compositions for hiv prevention and treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8087994A (en) * 1993-10-26 1995-05-22 Syntello Inc. Inhibition of hiv mucosal infection

Also Published As

Publication number Publication date
WO2004014945A1 (en) 2004-02-19
ITMI20021781A1 (en) 2004-02-07
AU2003255866A8 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
EP1390029A4 (en) Phenylindoles for the treatment of hiv
AU2002354107A1 (en) Exhaust ring mechanism, and plasma treatment device using the exhaust ring mechanism
AU2002367931A1 (en) Alumina-yttria-zirconium oxide/hafnium oxide materials, and methods of making and using the same
AP2081A (en) Oligomeric peptides and their use for the treatment of HIV infections
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU2001265253A1 (en) Treatment of hiv using hyperthermia
AU2003304246A1 (en) Method of forming nanostructures on ceramics and the ceramics formed
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2002363973A1 (en) Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
AU2003210659A1 (en) Combination therapy for treatment of hiv infection
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AU2003301012A1 (en) Use of beta-defensins for treating hiv infections
AU2002337843A1 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
AU2002333910A1 (en) Pharmaceutical composition for the treatment of viral, fungal and bacterial infections and applications of same
AU2003258983A1 (en) Combinations for the treatment of fungal infections
AU2003255866A1 (en) Gp41 epitope and uses thereof for the treatment of hiv infections
AU2003295163A1 (en) Composition for the treatment of hiv or aids
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2002325312A1 (en) Use of certain castanospermine esters in the treatment of influenza virus infections
AU2002360523A1 (en) Compounds to treat hiv infection and aids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase